Aiosyn Launches AI-powered Automated Quality Control to Improve the Digital Pathology Workflow
Aiosyn, a software company that develops AI-powered pathology software, has launched its first product that assists digital pathology labs across research, diagnostics and pharma to improve their quality control (QC) process. AiosynQC is an AI-powered algorithm that automatically scans for the most common artifacts that occur during the heterogeneous pre-analytical process.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230314005006/en/
Out-of-focus regions of an H&E stained slide image, blurry and difficult to read, are identified and highlighted with Aiosyn's automated quality control powered by AI. (Photo: Business Wire)
The algorithm of AiosynQC is trained on hematoxylin and eosin (H&E) stained slides. The product helps labs to ensure that only high-quality images are used by pathologists, technicians, and researchers. It can flag cases before presentation to a pathologist, thereby improving the efficiency of the digital pathology workflow by reducing the time that is currently used to manually check for artifacts in whole slide images.
AiosynQC is a modular and flexible software offered as a service solution that can be integrated into existing digital pathology software and deployed through the cloud or on-premise installation. The automated QC is the first product in Aiosyn’s workflow solutions suite. It will be part of a portfolio of deep learning algorithms currently in development for different pathologies for which there is a clear need to improve diagnostic precision and quality.
“AiosynQC will be an important foundational layer and we believe that AI-powered workflow solutions are the entry point for the use and adoption of computational pathology algorithms” according to Patrick de Boer, CEO of Aiosyn.
More information about AiosynQC can be found here.
About Aiosyn
Aiosyn is a Dutch medical software company that develops AI-powered pathology solutions that will be integrated into standard pathology workflows. The Aiosyn team has been built upon 20+ years of research experience in the field of pathology and is rooted into the pathology practice. More about Aiosyn can be found here.
AiosynQC
AiosynQC can only be used in the European Union and the United Kingdom. In the EU and the UK, AiosynQC is not considered a medical device under European IVDR and UK MDR 2002 legislation, respectively. AiosynQC is not intended to be used as an accessory to, nor is it necessary to be used in combination with, any AI or other medical devices to specifically enable them to meet their intended purpose or directly assist in their functionality.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230314005006/en/
Contact information
Anna Correas
contact@aiosyn.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeiGene to Present at the RBC Capital Markets Global Healthcare Conference13.5.2025 13:01:00 EEST | Press release
BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that will change its name to BeOne Medicines Ltd., today announced it will participate in the RBC Capital Markets Global Healthcare Conference on May 20, 2025, with a fireside chat at 10 a.m. EDT. The live webcast of this event can be accessed from the investors section of the Company’s website at http://ir.beigene.com/, https://hkexir.beigene.com/, https://sseir.beigene.com/. An archived replay will be available for 1 year following the event. About BeiGene BeiGene, which will change its name to BeOne Medicines, is a global oncology company that is discovering and developing innovative treatments that are more accessible and affordable to cancer patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need
IQM’s First Quantum Computer in Asia-Pacific Goes Online, Set to Open Office in Seoul13.5.2025 12:09:00 EEST | Press release
IQM Quantum Computers, a global leader in superconducting quantum computers, has announced expanding its presence in Asia-Pacific with a new office opening in South Korea in June 2025, following the installation of its first quantum system at Chungbuk National University (CBNU). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250513710683/en/ From left to right: Ben Lee and Mikko Välimäki of IQM Quantum Computers, Professor Kim Kiwoong of Chungbuk National University, Jyri Järviaho, Ambassador of Finland to South Korea, Jaana Tuomi, of Enter Espoo, Guensuk Ko of CBIST The office in Seoul reinforces IQM’s dedication to collaborating with research and academic institutions, high-performance computing (HPC) centers, and enterprises in advancing quantum technology. It also supports South Korea in building a vibrant quantum ecosystem and achieving the goals of its national quantum strategy. As part of the expansion, IQM has appoin
Ink Innovation and Riyadh Air Partner to Rethink Experience for Digital-first Travellers13.5.2025 12:06:00 EEST | Press release
Riyadh Air, the digitally native national carrier of Saudi Arabia, is joining forces with Ink Innovation to deliver a flexible and convenient air travel experience. Together, they aim to redefine standards of delivery management in a world influenced by e-commerce, cloud computing, and evolving traveller expectations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250513792260/en/ Tony Douglas, CEO of Riyadh Air, said: “Ink is a key partner to Riyadh Air and continues to foster innovation at every step of the journey. As a like-minded tech-innovator, it is an ideal collaborator as we aim to provide an outstanding digital experience for our guests at their first travel touchpoint.” Moving beyond legacy systems Airlines have long struggled with outdated infrastructure—systems built to move passengers from point A to B, but not to delight or adapt. This partnership aims to change that. Riyadh Air and Ink are implementing a full
Green Street Expands Private Market Coverage with European Self-Storage Data and Analytics13.5.2025 11:00:00 EEST | Press release
Green Street, the foremost provider of commercial real estate intelligence and insights, has expanded its private market research coverage to the European self-storage sector. Utilising 5 years of forecasted insights and 10 years of historical data, Green Street’s new Self-Storage Outlook focuses on investment opportunities available in 30 European cities. “Living quarters are becoming more compact and storage space is being cut back in urban developments, necessitating off-premises storage solutions for residential occupiers. Additionally, approximately 40% of the business customer base consists of small-to-medium-sized entities, particularly online retailers in the region,” said Marie Dormeuil, Head of European Market Analytics. “The growth in real spending on storable goods is expected to increase at 2% per annum over the next five years, supporting healthy demand growth.” Green Street continues to invest in product innovation and expanding its breadth of research coverage by unveil
Oracle and Infobip Enhance Partnership to Deliver Global Conversational Experiences13.5.2025 11:00:00 EEST | Press release
Global cloud communications platform Infobip today announced that it has enhanced its partnership with Oracle to bring conversational experiences to businesses and brands globally. The new integration enables Infobip and Oracle customers and partners to access Infobip's omnichannel services through Oracle Integration. Customers increasingly expect omnichannel communications, but integrating and managing new channels can be time-consuming, requiring complex development, deployment, and organizational processes. Infobip’s new Omnichannel Messaging Adapter for Oracle Integration addresses this challenge byenabling all types of businesses to work with and manage omnichannel messaging channels involving Oracle and third-party solutions, including WhatsApp and RCS. The solution deploys quickly, reducing time to market. In addition, Infobip has provided a prebuilt use case – or Accelerator – for Oracle’s contact center solution, Oracle B2C Service. This Accelerator is a flexible solution that
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom